56
Views
1
CrossRef citations to date
0
Altmetric
Review

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures

&
Pages 13-20 | Published online: 13 Jan 2011

References

  • MarchettiOBilleJFluckigerUEpidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991–2000Clin Infect Dis200438331132014727199
  • WisplinghoffHBischoffTTallentSMSeifertHWenzelRPEdmondMBNosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance studyClin Infect Dis200439330931715306996
  • National Nosocomial Infections Surveillance SystemNational Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003Am J Infect Control200331848149814647111
  • KaoASBrandtMEPruittWRThe epidemiology of candidemia in two United States cities: Results of a population-based active surveillanceClin Infect Dis19992951164117010524958
  • Abi-SaidDAnaissieEUzunORaadIPinzcowskiHVartivarianSThe epidemiology of hematogenous candidiasis caused by different Candida speciesClin Infect Dis1997246112211289195068
  • VincentJLAnaissieEBruiningHEpidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive careIntensive Care Med19982432062169565801
  • BlumbergHMJarvisWRSoucieJMNational Epidemiology of Mycoses Survey (NEMIS) Study Group. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis SurveyClin Infect Dis200133217718611418877
  • WeySBMoriMPfallerMAWoolsonRFWenzelRPHospital-acquired candidemia. The attributable mortality and excess length of stayArch Intern Med198814812264226453196127
  • WenzelRPNosocomial candidemia: Risk factors and attributable mortalityClin Infect Dis1995206153115347548504
  • RentzAMHalpernMTBowdenRThe impact of candidemia on length of hospital stay, outcome, and overall cost of illnessClin Infect Dis19982747817889798034
  • TortoranoAMPemanJBernhardtHECMM Working Group on CandidaemiaEpidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance studyEur J Clin Microbiol Infect Dis200423431732215029512
  • AlmiranteBRodríguezDParkBJBarcelona Candidemia Project Study GroupEpidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003J Clin Microbiol20054341829183515815004
  • BlotSIVandewoudeKHEstimating attributable mortality of candidemia: Clinical judgement vs matched cohort studiesEur J Clin Microbiol Infect Dis200322213213312627293
  • FalagasMEApostolouKEPappasVDAttributable mortality of candidemia: A systematic review of matched cohort and case-control studiesEur J Clin Microbiol Infect Dis200625741942516773391
  • PelzRKLipsettPASwobodaSMCandida infections: Outcome and attributable ICU costs in critically ill patientsJ Intensive Care Med2000155255261
  • PelzRKLipsettPASwobodaSMDiener-WestMHammondJMHendrixCWThe diagnostic value of fungal surveillance cultures in critically ill patientsSurg Infect (Larchmt)20001427328112594883
  • PittetDMonodMSuterPMFrenkEAuckenthalerRCandida colonization and subsequent infections in critically ill surgical patientsAnn Surg199422067517587986142
  • EggimannPOstrosky-ZeichnerLEarly antifungal intervention strategies in ICU patientsCurr Opin Crit Care201016546546920827073
  • VardakasKZSamonisGMichalopoulosASoteriadesESFalagasMEAntifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trialsCrit Care Med20063441216122416484923
  • CrucianiMde LallaFMengoliCProphylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and meta-analysisIntensive Care Med200531111479148716172847
  • PlayfordEGWebsterACSorrellTCCraigJCAntifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trialsJ Antimicrob Chemother200657462863816459344
  • ShorrAFChungKJacksonWLWatermanPEKollefMHFluconazole prophylaxis in critically ill surgical patients: A meta-analysisCrit Care Med20053391928193516148461
  • HoKMLipmanJDobbGJWebbSAThe use of prophylactic fluconazole in immunocompetent high-risk surgical patients: A meta-analysisCrit Care200596R710R71716280069
  • OlaecheaPMPalomarMLeón-GilCEPCAN Study GroupEconomic impact of Candida colonization and Candida infection in the critically ill patientEur J Clin Microbiol Infect Dis200423432333015024623
  • PappasPGKauffmanCAAndesDInfectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of AmericaClin Infect Dis200948550353519191635
  • PiarrouxRGrenouilletFBalvayPAssessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patientsCrit Care Med200432122443244915599149
  • BerrouaneYFHerwaldtLAPfallerMATrends in antifungal use and epidemiology of nosocomial yeast infections in a university hospitalJ Clin Microbiol19993735315379986807
  • NguyenMHPeacockJEJrMorrisAJThe changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistanceAm J Med199610066176238678081
  • GleasonTGMayAKCaparelliDFarrBMSawyerRGEmerging evidence of selection of fluconazole-tolerant fungi in surgical intensive care unitsArch Surg199713211119712029366712
  • KlingsporLTörnqvistEJohanssonAPetriniBForsumUHedinGA prospective epidemiological survey of candidaemia in SwedenScand J Infect Dis2004361525515000560
  • MorganJGlobal trends in candidemia: Review of reports from 1995–2005Curr Infect Dis Rep20057642943916225780
  • DimopoulosGNtzioraFRachiotisGArmaganidisAFalagasMECandida albicans versus non-albicans intensive care unit-acquired bloodstream infections: Differences in risk factors and outcomeAnesth Analg2008106252352918227310
  • KovacicovaGKrupovaYLovaszovaMAntifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and noncancer patient population: Is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?J Infect Chemother20006421622111810569
  • MagillSSSwobodaSMShieldsCEThe epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: Follow-up to a randomized clinical trialAnn Surg2009249465766519300221
  • PelzRKHendrixCWSwobodaSMDouble-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patientsAnn Surg2001233454254811303137
  • FaizSNealeBRiosERisk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unitEur J Clin Microbiol Infect Dis200928668969219011913
  • EggimannPGarbinoJPittetDEpidemiology of Candida species infections in critically ill non-immunosuppressed patientsLancet Infect Dis200331168570214592598